GlassScriptPhysician profile
Meredith A White
NPI 1811346307
$551.46
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $551.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $103.79 | 2022 | |
| Abbvie INC. | $71.43 | 2022 | |
| Corcept Therapeutics | $49.86 | 2022 | |
| Eusa Pharma (US) LLC | $49.45 | 2022 | |
| Recordati_rare_diseases_inc. | $49.45 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $49.04 | 2022 | |
| Novo Nordisk INC | $42.80 | 2022 | |
| Ibsa Pharma INC. | $34.94 | 2022 | |
| Esperion Therapeutics, INC. | $33.99 | 2022 | |
| Antares Pharma, INC. | $16.54 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.79 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $12.62 | 2022 | |
| Lundbeck LLC | $11.99 | 2022 | |
| Bausch Health US, LLC | $11.77 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.